CVE-2014-1994
Cross-site scripting (XSS) vulnerability in the Notices portlet in Cybozu Garoon 2.x and 3.x...
Cross-site scripting (XSS) vulnerability in the Notices portlet in Cybozu Garoon 2.x and 3.x before 3.7 SP4 allows remote authenticated users to inject arbitrary web script or HTML via unspecified vectors.
Exploit likelihood
What each source reports
NVD Score used
Cross-site scripting (XSS) vulnerability in the Notices portlet in Cybozu Garoon 2.x and 3.x before 3.7 SP4 allows remote authenticated users to inject arbitrary web script or HTML via unspecified vectors.
- Record
CVE-2014-1994- CVSS 2.0
- 3.5 Low
AV:N/AC:M/Au:S/C:N/I:P/A:N - Weakness
- CWE-79
- Updated
- 2026-11-02
CVE List No score
Cross-site scripting (XSS) vulnerability in the Notices portlet in Cybozu Garoon 2.x and 3.x before 3.7 SP4 allows remote authenticated users to inject arbitrary web script or HTML via unspecified vectors.
- Record
CVE-2014-1994- Updated
- 2026-11-02
EUVDEUVD-2014-2046 No score
Cross-site scripting (XSS) vulnerability in the Notices portlet in Cybozu Garoon 2.x and 3.x before 3.7 SP4 allows remote authenticated users to inject arbitrary web script or HTML via unspecified vectors.
- Record
EUVD-2014-2046- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-p7gm-34jm-q5gp No score
Cross-site scripting (XSS) vulnerability in the Notices portlet in Cybozu Garoon 2.x and 3.x...
Cross-site scripting (XSS) vulnerability in the Notices portlet in Cybozu Garoon 2.x and 3.x before 3.7 SP4 allows remote authenticated users to inject arbitrary web script or HTML via unspecified vectors.
- Record
GHSA-p7gm-34jm-q5gp- Weakness
- CWE-79
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2014-1994 is a low vulnerability (CVSS 3.5) in Cybozu Garoon, published July 20, 2014. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.94%, the 60th percentile. No source names a fixed version.